Monthly Prescribing Reference

Abbott’s SCS Systems Approved for Nonsurgical Refractory Back Pain

Credit: Shutterstock. Study participants suffered from chronic back pain for an average of 12.8 years. The Food and Drug Administration (FDA) has expanded the approval of Abbott’s spinal cord ...
Benzinga.com

Back Off, Chronic Pain! FDA Nods for Abbott's Spinal Cord Stimulation Devices

The FDA approved Abbott Laboratories ABT spinal cord stimulation (SCS) devices for chronic back pain in people who have not had or are not eligible to receive back surgery, known as non-surgical back ...
Morningstar

New Data Show Significant Pain Relief, Reduced Opioid Use, Decreased Patient Time and Cost Burdens with the ProsperaTM SCS System

24-month interim results from the first long-term study of SCS with automatic, objective, daily remote monitoring presented at NANS 2025 Annual Meeting This system integrates RESONANCE™ multiphase ...
Business Wire

St. Jude Medical Announces FDA Approval of the Proclaim Elite SCS System, a Patient-Centric, Recharge-Free, Upgradeable and MR-conditional Chronic Pain Treatment Option

“The approval of the Proclaim Elite recharge-free SCS system is a needed advancement for both patients and physicians who now have access to a low-maintenance chronic pain treatment that can reduce ...
Nasdaq

DTM™ Spinal Cord Stimulation Using the Medtronic Intellis™ Platform Shows Superior Back Pain Relief Compared to Conventional SCS Therapy in an RCT

At Three-Months, 80% of Patients Treated with DTM SCS Reported Back Pain Reliefof at Least 50%; 63% Reported Profound Back Pain Relief of 80% or Greater1 The RCT demonstrated profound pain relief and ...
Business Wire

Spinal Modulation Axium™ Spinal Cord Stimulator System (SCS) Shows Promise in Managing Chronic Pain in Difficult Pain Conditions

LAS VEGAS, Nev.--(BUSINESS WIRE)--During the scientific sessions at the 16 th Annual NANS Conference, Dr. Liong Liem, Anesthesiologist at Sint Antonius Ziekenhuis in the Netherlands and member of the ...